Celularity Inc.
NASDAQ:CELU
1.55 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 14.681 | 12.112 | 3.786 | 2.938 | 3.935 | 4.129 | 4.135 | 3.776 | 5.935 | 4.857 | 10.622 | 3.197 | 2.66 | 3.243 | 3.355 | 3.472 | 4.208 | 5.151 | 0 | 0 | 0 |
| Cost of Revenue
| 1.64 | 9.609 | 3.602 | 1.045 | 25.678 | 5.247 | 7.213 | 3.179 | 4.026 | 4.66 | 2.311 | 1.44 | 1.242 | 1.17 | 1.033 | 0.208 | 0.242 | 0.564 | 0.202 | 0.115 | 0 |
| Gross Profit
| 13.041 | 2.503 | 0.184 | 1.893 | -21.743 | -1.118 | -3.078 | 0.597 | 1.909 | 0.197 | 8.311 | 1.757 | 1.418 | 2.073 | 2.322 | 3.264 | 3.966 | 4.587 | -0.202 | -0.115 | 0 |
| Gross Profit Ratio
| 0.888 | 0.207 | 0.049 | 0.644 | -5.526 | -0.271 | -0.744 | 0.158 | 0.322 | 0.041 | 0.782 | 0.55 | 0.533 | 0.639 | 0.692 | 0.94 | 0.943 | 0.89 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 5.843 | -0.272 | 5.182 | 8.604 | 16.951 | 10.99 | 20.351 | 25.349 | 21.673 | 24.687 | 23.765 | 22.911 | 16.99 | 13.924 | 11.217 | 15.804 | 11.762 | 12.75 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 13.024 | 0 | 0 | 0 | 18.917 | 0 | 0 | 0 | 12.956 | 0 | 0 | 0 | 0.242 | 7.683 | 6.556 | 0.242 | 0.247 | 0.202 | 0.115 | 0 |
| Selling & Marketing Expenses
| 0 | 0.044 | 0 | 0 | 0 | 0.163 | 0 | 0 | 0 | 0.252 | 0 | 0 | 0 | 5.731 | 0.644 | 1.03 | 0 | 1.158 | 0 | 0 | 0 |
| SG&A
| 14.028 | 13.068 | 10.748 | 12.826 | 13.934 | 19.08 | 14.907 | 15.574 | 16.46 | 13.208 | 21.644 | 28.863 | 7.626 | 5.973 | 8.327 | 7.586 | 0.242 | 0.247 | 0.202 | 0.115 | 0 |
| Other Expenses
| 0.546 | -2.586 | 1.141 | -4.301 | 0.541 | 0.553 | 0.987 | 0.546 | 0.541 | 34.429 | -0.109 | -3.178 | -0.027 | -0.003 | 0.504 | 0.208 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 20.417 | -10.812 | 16.726 | 21.976 | 31.426 | 30.623 | 35.811 | 41.469 | 38.674 | 37.895 | 45.962 | 52.32 | 25.157 | 20.448 | 20.327 | 0.208 | 0.242 | 0.247 | 0.202 | 0.115 | 0 |
| Operating Income
| -7.376 | 13.315 | -99.256 | -42.476 | -63.87 | 17.485 | -5.646 | -40.872 | -36.765 | -14.95 | 10.898 | -60.611 | -44.395 | 11.055 | -4.806 | -0.208 | -0.242 | -0.247 | -0.202 | -0.115 | -0 |
| Operating Income Ratio
| -0.502 | 1.099 | -26.217 | -14.457 | -16.231 | 4.235 | -1.365 | -10.824 | -6.195 | -3.078 | 1.026 | -18.959 | -16.69 | 3.409 | -1.432 | -0.06 | -0.057 | -0.048 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -14.637 | -3.21 | -76.386 | -26.828 | -0.147 | 6.962 | 43.563 | 88.715 | -26.102 | 34.429 | 88.377 | -13.226 | -57.188 | 22.806 | -27.691 | -12.438 | 1.539 | 1.206 | 1.621 | 0.919 | 0 |
| Income Before Tax
| -22.013 | 9.557 | -93.876 | -47.949 | -64.017 | 24.447 | 4.782 | 47.843 | -62.867 | -4.02 | 49.938 | -64.477 | -81.539 | 3.841 | -46.31 | -12.148 | 1.297 | 0.959 | 1.419 | 0.803 | -0 |
| Income Before Tax Ratio
| -1.499 | 0.789 | -24.796 | -16.32 | -16.269 | 5.921 | 1.156 | 12.67 | -10.593 | -0.828 | 4.701 | -20.168 | -30.654 | 1.184 | -13.803 | -3.499 | 0.308 | 0.186 | 0 | 0 | 0 |
| Income Tax Expense
| -13.489 | 0.01 | 2.112 | -3.197 | 0.424 | 0.013 | -0.017 | 0.017 | 26.102 | 0.02 | 0.734 | 0.044 | 0.044 | -0.069 | 0.015 | -0.038 | 0.273 | 0.202 | 0.298 | 0.169 | -0.04 |
| Net Income
| -22.013 | 9.547 | -93.876 | -47.949 | -64.017 | 24.434 | 4.799 | 47.826 | -62.867 | -4.039 | 49.938 | -64.477 | -81.539 | 3.91 | -46.325 | -12.11 | 1.025 | 0.757 | 1.121 | 0.635 | -0 |
| Net Income Ratio
| -1.499 | 0.788 | -24.796 | -16.32 | -16.269 | 5.918 | 1.161 | 12.666 | -10.593 | -0.832 | 4.701 | -20.168 | -30.654 | 1.206 | -13.808 | -3.488 | 0.244 | 0.147 | 0 | 0 | 0 |
| EPS
| -1.03 | 0.54 | -5 | -2.72 | -4.12 | 1.67 | 0.3 | 3.41 | -4.82 | -0.33 | 4.69 | -5.26 | -6.66 | 0.032 | -7.56 | -1.98 | 0.43 | 0.32 | 0.47 | 0.27 | -0 |
| EPS Diluted
| -1.03 | 0.54 | -4.98 | -2.72 | -4.12 | 1.24 | 0.3 | 3.2 | -4.82 | -0.33 | 4 | -5.26 | -6.66 | 0.032 | -7.56 | -1.98 | 0.43 | 0.32 | 0.47 | 0.27 | -0 |
| EBITDA
| -18.709 | 13.14 | -13.035 | -21.996 | -52.411 | -32.836 | -35.4 | -38.097 | -34.802 | -3.261 | -37.152 | -53.066 | -21.69 | -16.411 | -16.626 | 12.23 | 1.297 | 0.959 | 1.419 | 0.803 | -0 |
| EBITDA Ratio
| -1.274 | 1.085 | -3.443 | -7.487 | -13.319 | -7.953 | -8.561 | -10.089 | -5.864 | -0.671 | -3.498 | -16.599 | -8.154 | -5.06 | -4.956 | 3.522 | 0.308 | 0.186 | 0 | 0 | 0 |